glp-1 news 2025 november Receptor Agonist Market Size and Share 2025 dominates for GLP-1 trial

Be Honest and Detailed: When discussing your symptoms with your doctor, be as detailed as possible

Salmon or fatty fish twice weekly

Analysis of nearly 8,000 adults found 45% keep the weight off after one year As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings

In contrast, the number of those dispensed drugs other than GLP-1 receptor agonists fell from 12,683,040 to 12,282,525, for a decrease of 3.1%

this can be summarized as 1 of 6 patients experiencing a WR of 10% or more post MBS

Both are common, and both can be managed with a few targeted adjustments